Cover Image

Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants

In April 2020, the Ministry of Food and Drug Safety licensed a hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP), inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib) conjugated to tetanus protein, and hepatitis B (HepB) (recombinant DNA) vaccine, DTa-PIP...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hye-Kyung Cho (Author), Su Eun Park (Author), Yae-Jean Kim (Author), Dae Sun Jo (Author), Yun-Kyung Kim (Author), Byung-Wook Eun (Author), Taek-Jin Lee (Author), Jina Lee (Author), Hyunju Lee (Author), Ki Hwan Kim (Author), Eun Young Cho (Author), Jong Gyun Ahn (Author), Eun Hwa Choi (Author)
Format:	Book
Published:	The Korean Pediatric Society, 2021-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adverse Effects of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine in 6- to 7-Year-Old Children
by: Sung-Hsi Wei, et al.
Published: (2011)

Hepatitis B Response of Premature Infants after Primary and Booster Immunisation with a Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Inactivated Poliovirus/Haemophilus Influenzae Type B Vaccine
by: Felix Omeñaca, et al.
Published: (2010)

Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) in Korean children
by: Soon Min Lee, et al.
Published: (2019)

Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India
by: Hitt J Sharma, et al.
Published: (2023)

Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants
by: Yanping Li, et al.
Published: (2017)

Antibody persistence to diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens, and Haemophilus influenzae type b following primary and first booster with pentavalent versus hexavalent vaccines
by: Nasamon Wanlapakorn, et al.
Published: (2024)

Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States
by: Nicola P. Klein, et al.
Published: (2019)

A phase 2 study of a combined diphtheria-tetanus-acellular pertussis vaccine with a Sabin-derived inactivated poliovirus vaccine in children
by: Takashi Nakano, et al.
Published: (2018)

Serum sickness-like reaction after diphtheria, tetanus, acellular pertussis, inactivated polio and Haemophilus influenzae type b conjugate (5-in-1 vaccine) vaccination: A case report
by: Wei-Yu Chen, et al.
Published: (2020)

Predictors of Tetanus-Diphtheria- Acellular Pertussis Vaccination Among Adults Receiving Tetanus Vaccine in the United States
by: Tracy L. Johns, et al.
Published: (2013)

Myocarditis following diphtheria, whole-cell pertussis, and tetanus toxoid vaccination in a young infant
by: Vivek Kumar, et al.
Published: (2018)

Frequency of apnea, bradycardia, and desaturations following first diphtheria-tetanus-pertussis-inactivated polio-<it>Haemophilus influenzae </it>type B immunization in hospitalized preterm infants
by: Spady Donald W, et al.
Published: (2006)

Mass psychogenic illness following tetanus-diphtheria toxoid vaccination in Jordan
by: Kharabsheh Saad, et al.
Published: (2001)

SAFETY OF PEDIATRIC COMBINATED VACCINE FOR DIPHTHERIA, PERTUSSIS, TETANUS, POLIO AND HAEMOPHILUS INFLUENZA TYPE B IN THE PRIMARY IMMUNIZATION AND FIRST BOOSTERISATION
by: N. D. Chernova, et al.
Published: (2012)

Attitudes of US Obstetricians Toward a Combined Tetanus-Diphtheria-Acellular Pertussis Vaccine for Adults
by: Sarah J. Clark, et al.
Published: (2006)

Concomitant administration of diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine derived from Sabin strains (DTaP-sIPV) with pentavalent rotavirus vaccine in Japanese infants
by: Yoshiyuki Tanaka, et al.
Published: (2017)

Recommended immunization schedule for children and adolescents: Committee on Infectious Diseases of the Korean Pediatric Society, 2018
by: Eun Hwa Choi, et al.
Published: (2019)

THE EXPERIENCE OF A COMBINED VACCINE AGAINST DIPHTHERIA, PERTUSSIS, TETANUS, POLIO AND HAEMOPHILUS INFLUENZAE TYPE B IN HEALTHY CHILDREN AND CHILDREN WITH VARIOUS DISABILITIES
by: O.A. Rychkova, et al.
Published: (2011)

THE EXPERIENCE OF A COMBINED VACCINE AGAINST DIPHTHERIA, PERTUSSIS, TETANUS, POLIO AND HAEMOPHILUS INFLUENZAE TYPE B IN HEALTHY CHILDREN AND CHILDREN WITH VARIOUS DISABILITIES
by: O.A. Rychkova, et al.
Published: (2011)

Factors associated with receipt of Tetanus, Diphtheria, and Acellular Pertussis Vaccine (Tdap) in mothers who deliver preterm
by: Shetal I. Shah, et al.
Published: (2023)

A prospective, observational, multi-center, post-marketing safety surveillance study of the GSK combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b invasive infections (DTaP-IPV/Hib) in South Korean infants
by: Diego Mpia Elenge, et al.
Published: (2024)

Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine
by: C. Panpitpat, et al.
Published: (2000)

Tetanus, Diphtheria, and Acellular Pertussis Vaccination Coverage Among Publicly Insured Pregnant Women, U.S., 2016-2019
by: Cheryl J. Isenhour, DVM, et al.
Published: (2023)

Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases
by: Peter Van den Steen, et al.
Published: (2023)

Statement on healthcare system preparedness in response to COVID-19 Omicron subvariants BA.4 and BA.5 surge in Korea from the Korean Pediatric Society and Korean Society of Pediatric Infectious Diseases
by: Eun Young Cho, et al.
Published: (2022)

Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults
by: Chukiat Sirivichayakul, et al.
Published: (2017)

Antenatal tetanus, diphtheria, and acellular pertussis (Tdap) immunization and risk of serogroup 19 IPD in children: An indirect cohort study
by: Melina Thibault, et al.
Published: (2024)

A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults
by: Geert Leroux-Roels, et al.
Published: (2018)

Stability of tetanus toxoid microcapsules
by: Krisana Sethpiyanon
Published: (2014)

Recommended immunization schedule for children and adolescents: Immunization Guideline (8th edition) released by the Korean Pediatric Society in 2015
by: Jong-Hyun Kim, et al.
Published: (2016)

Recommended immunization schedule for children and adolescents: the Korean Pediatric Society, 2013
by: Dae Sun Jo, et al.
Published: (2013)

Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study
by: Martina Kovac, et al.
Published: (2018)

Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus
by: Deming Michael S., et al.
Published: (2002)

Guillain Barré syndrome after combined diphtheria, tetanus, and acellular pertussis (DTaP) vaccine: A rare pediatric case report and review of literature
by: Meichen Pan, et al.
Published: (2023)

Erythema multiforme induced by tetanus toxoid vaccine
by: Deepa Chaudhary, et al.
Published: (2020)

Serum Sickness following Tetanus Toxoid Injection
by: Saja alhawal, et al.
Published: (2021)

Safety and use of tetanus-diphtheria-acellular pertussis-5 (Tdap5) vaccine during pregnancy: findings from 11 years of reporting to a pregnancy registry
by: Charlotte Switzer, et al.
Published: (2021)

Adverse events following immunization of combined diphtheria, whole-cell pertussis, tetanus, and hepatitis B (DPwT/HB) vaccine
by: Diana Mettadewi Jong, et al.
Published: (2016)

Impact of childhood and maternal vaccination against diphtheria, tetanus, and pertussis in Colombia
by: María Cristina Hoyos, et al.
Published: (2021)

RESULTS OF ADMINISTRATION OF COMBINED VACCINE AGAINST DIPHTHERIA, PERTUSSIS, TETANUS, POLIOMYELITIS AND HAEMOPHILIC INFECTION TYPE B IN CHILDREN WITH CONCOMITANT DISEASES
by: N. F. Snegova, et al.
Published: (2011)